Literature DB >> 2900937

Parkinson's disease after antithyroid treatment.

B Verges, M Giroud, A Richard, F Giroud-Baleydier, G Vaillant, B Lorcerie, J M Brun, R Putelat.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 2900937     DOI： 10.1016/s0140-6736(88)92677-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Graves' disease presenting as hemiparkinsonism.

Authors:  J S Davies; P K Morrish; M F Scanlon
Journal:  J Endocrinol Invest       Date:  2001-03       Impact factor: 4.256

2.  Ultrasensitive TSH assay and anti-parkinsonian treatment with levodopa.

Authors:  B Vergès; M Giroud; G Vaillant; B Verges-Patois; J M Brun; R Putelat
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

3.  The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases.

Authors:  Caitlin M Daimon; Patrick Chirdon; Stuart Maudsley; Bronwen Martin
Journal:  Am J Alzheimers Dis (Columbia)       Date:  2013

4.  Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats.

Authors:  Ippolita Cantuti-Castelvetri; Ledia F Hernandez; Christine E Keller-McGandy; Lauren R Kett; Alex Landy; Zane R Hollingsworth; Esen Saka; Jill R Crittenden; Eduardo A Nillni; Anne B Young; David G Standaert; Ann M Graybiel
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.